Amelioration of elastase-induced lung emphysema and reversal of pulmonary hypertension by pharmacological iNOS inhibition in mice.
Journal
British journal of pharmacology
ISSN: 1476-5381
Titre abrégé: Br J Pharmacol
Pays: England
ID NLM: 7502536
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
03
05
2019
revised:
12
02
2020
accepted:
10
03
2020
pubmed:
24
3
2020
medline:
22
6
2021
entrez:
24
3
2020
Statut:
ppublish
Résumé
Chronic obstructive pulmonary disease, encompassing chronic airway obstruction and lung emphysema, is a major worldwide health problem and a severe socio-economic burden. Evidence previously provided by our group has shown that inhibition of inducible NOS (iNOS) prevents development of mild emphysema in a mouse model of chronic tobacco smoke exposure and can even trigger lung regeneration. Moreover, we could demonstrate that pulmonary hypertension is not only abolished in cigarette smoke-exposed iNOS We have established a mouse model using a single dose of porcine pancreatic elastase or saline, intratracheally instilled in C57BL/6J mice. Emphysema, as well as pulmonary hypertension development was determined by both structural and functional measurements. Our data revealed that (i) emphysema is fully established after 21 days, with the same degree of emphysema after 21 and 28 days post instillation, (ii) emphysema is stable for at least 12 weeks and (iii) pulmonary hypertension is evident, in contrast to smoke models, only after emphysema development. Oral treatment with the iNOS inhibitor N(6)-(1-iminoethyl)-l-lysine (L-NIL) was started after emphysema establishment and continued for 12 weeks. This resulted in significant lung regeneration, evident in the improvement of emphysema and reversal of pulmonary hypertension. Our data indicate that iNOS is a potential new therapeutic target to treat severe emphysema and associated pulmonary hypertension. This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.1/issuetoc.
Sections du résumé
BACKGROUND AND PURPOSE
Chronic obstructive pulmonary disease, encompassing chronic airway obstruction and lung emphysema, is a major worldwide health problem and a severe socio-economic burden. Evidence previously provided by our group has shown that inhibition of inducible NOS (iNOS) prevents development of mild emphysema in a mouse model of chronic tobacco smoke exposure and can even trigger lung regeneration. Moreover, we could demonstrate that pulmonary hypertension is not only abolished in cigarette smoke-exposed iNOS
EXPERIMENTAL APPROACH
We have established a mouse model using a single dose of porcine pancreatic elastase or saline, intratracheally instilled in C57BL/6J mice. Emphysema, as well as pulmonary hypertension development was determined by both structural and functional measurements.
KEY RESULTS
Our data revealed that (i) emphysema is fully established after 21 days, with the same degree of emphysema after 21 and 28 days post instillation, (ii) emphysema is stable for at least 12 weeks and (iii) pulmonary hypertension is evident, in contrast to smoke models, only after emphysema development. Oral treatment with the iNOS inhibitor N(6)-(1-iminoethyl)-l-lysine (L-NIL) was started after emphysema establishment and continued for 12 weeks. This resulted in significant lung regeneration, evident in the improvement of emphysema and reversal of pulmonary hypertension.
CONCLUSION AND IMPLICATIONS
Our data indicate that iNOS is a potential new therapeutic target to treat severe emphysema and associated pulmonary hypertension.
LINKED ARTICLES
This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.1/issuetoc.
Substances chimiques
Smoke
0
Pancreatic Elastase
EC 3.4.21.36
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
152-171Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : 268555672
Informations de copyright
© 2020 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
Références
Alexander, S. P. H., Roberts, R. E., Broughton, B. R. S., Sobey, S. G., George, C. H., Stanford, S. C., … Ahluwalia, A. (2018). Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology. British journal of pharmacology, 175, 407-411. https://doi.org/10.1111/bph.14112
Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., … Sharman, J. L. (2019). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes. British Journal of Pharmacology, 176, S297-S396.
Antunes, M. A., Abreu, S. C., Cruz, F. F., Teixeira, A. C., Lopes-Pacheco, M., Bandeira, E., … Rocco, P. R. M. (2014). Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema. Respiratory Research, 15, 118. https://doi.org/10.1186/s12931-014-0118-x
Antunes, M. A., & Rocco, P. R. (2011). Elastase-induced pulmonary emphysema: insights from experimental models. Anais da Academia Brasileira de Ciências, 83, 1385-1396. https://doi.org/10.1590/s0001-37652011005000039
Barkauskas, C. E., Cronce, M. J., Rackley, C. R., Bowie, E. J., Keene, D. R., Stripp, B. R., … Hogan, B. L. (2013). Type 2 alveolar cells are stem cells in adult lung. The Journal of Clinical Investigation, 123, 3025-3036. https://doi.org/10.1172/JCI68782
Bartesaghi, S., & Radi, R. (2018). Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration. Redox Biology, 14, 618-625.
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990). Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proceedings of the National Academy of Sciences of the United States of America, 87, 1620-1624. https://doi.org/10.1073/pnas.87.4.1620
Bohadana, A. B., Nilsson, F., Westin, A., Martinet, N., & Martinet, Y. (2006). Smoking cessation--but not smoking reduction--improves the annual decline in FEV1 in occupationally exposed workers. Respiratory Medicine, 100, 1423-1430. https://doi.org/10.1016/j.rmed.2005.11.005
Boyer, L., Plantier, L., Dagouassat, M., Lanone, S., Goven, D., Caramelle, P., … Boczkowski, J. (2011). Role of nitric oxide synthases in elastase-induced emphysema. Laboratory Investigation, 91, 353-362. https://doi.org/10.1038/labinvest.2010.169
Cazzola, M., Donner, C. F., & Hanania, N. A. (2007). One hundred years of chronic obstructive pulmonary disease (COPD). Respiratory Medicine, 101, 1049-1065. https://doi.org/10.1016/j.rmed.2007.01.015
Chelladurai, P., Seeger, W., & Pullamsetti, S. S. (2012). Matrix metalloproteinases and their inhibitors in pulmonary hypertension. The European Respiratory Journal, 40, 766-782. https://doi.org/10.1183/09031936.00209911
Conlon, T. M., Bartel, J., Ballweg, K., Gunter, S., Prehn, C., Krumsiek, J., … Yildirim, A. Ö. (2016). Metabolomics screening identifies reduced L-carnitine to be associated with progressive emphysema. Clinical Science (London, England), 130, 273-287. https://doi.org/10.1042/CS20150438
Couillin, I., Vasseur, V., Charron, S., Gasse, P., Tavernier, M., Guillet, J., … Ryffel, B. (2009). IL-1R1/MyD88 signaling is critical for elastase-induced lung inflammation and emphysema. Journal of Immunology, 183, 8195-8202. https://doi.org/10.4049/jimmunol.0803154
Cruz, F. F., Antunes, M. A., Abreu, S. C., Fujisaki, L. C., Silva, J. D., Xisto, D. G., … Rocco, P. R. (2012). Protective effects of bone marrow mononuclear cell therapy on lung and heart in an elastase-induced emphysema model. Respiratory Physiology & Neurobiology, 182, 26-36. https://doi.org/10.1016/j.resp.2012.01.002
Curtis, M. J., Alexander, S., Cirino, G., Docherty, J. R., George, G. H., Giembycz, M. A., et al. (2018). Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. British Journal of Pharmacology, 175(7), 987-993. https://doi.org/10.1111/bph.14153
de Novaes Rocha, N., de Oliveira, M. V., Braga, C. L., Guimaraes, G., de Albuquerque Maia, L., de Araújo Padilha, G., … Rocco, P. R. (2017). Ghrelin therapy improves lung and cardiovascular function in experimental emphysema. Respiratory Research, 18, 185. https://doi.org/10.1186/s12931-017-0668-9
Dijkstra, G., Moshage, H., van Dullemen, H. M., de Jager-Krikken, A., Tiebosch, A. T., Kleibeuker, J. H., … van Goor, H. (1998). Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. The Journal of Pathology, 186, 416-421. https://doi.org/10.1002/(SICI)1096-9896(199812)186:4<416::AID-PATH201>3.0.CO;2-U
Elwing, J., & Panos, R. J. (2008). Pulmonary hypertension associated with COPD. International Journal of Chronic Obstructive Pulmonary Disease, 3, 55-70.
Emami, K., Cadman, R. V., Woodburn, J. M., Fischer, M. C., Kadlecek, S. J., Zhu, J., … Friscia, M. E. (2008). Early changes of lung function and structure in an elastase model of emphysema-A hyperpolarized 3He MRI study. Journal of Applied Physiology, 104, 773-786.
Fournier, M., & Lewis, M. I. (2000). Functional, cellular, and biochemical adaptations to elastase-induced emphysema in hamster medial scalene. Journal of Applied Physiology, 88, 1327-1337.
Girard, A., Jouneau, S., Chabanne, C., Khouatra, C., Lannes, M., Traclet, J., … Cottin, V. (2015). Severe pulmonary hypertension associated with COPD: hemodynamic improvement with specific therapy. Respiration, 90, 220-228. https://doi.org/10.1159/000431380
Harding, S. D., Sharman, J. L., Faccenda, E., Southan, C., Pawson, A. J., Ireland, S., … NC-IUPHAR. (2018). The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY. Nucleic Acids Research, 46, D1091-d1106. https://doi.org/10.1093/nar/gkx1121
Hensley, K., Maidt, M. L., Yu, Z., Sang, H., Markesbery, W. R., & Floyd, R. A. (1998). Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. The Journal of Neuroscience, 18, 8126-8132.
Hirai, T., Hosokawa, M., Kawakami, K., Takubo, Y., Sakai, N., Oku, Y., … Kuno, K. (1995). Age-related changes in the static and dynamic mechanical properties of mouse lungs. Respiration Physiology, 102, 195-203. https://doi.org/10.1016/0034-5687(95)00068-2
Hothorn, T., Bretz, F., & Westfall, P. (2008). Simultaneous Inference in general parametric models. Biometrical Journal, 50, 346-363. https://doi.org/10.1002/bimj.200810425
Houghton, A. M. (2015). Matrix metalloproteinases in destructive lung disease. Matrix Biology, 44-46, 167-174. https://doi.org/10.1016/j.matbio.2015.02.002
Ishizawa, K., Kubo, H., Yamada, M., Kobayashi, S., Numasaki, M., Ueda, S., … Sasaki, H. (2004). Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Letters, 556, 249-252. https://doi.org/10.1016/s0014-5793(03)01399-1
Janssen, W., Schymura, Y., Novoyatleva, T., Kojonazarov, B., Boehm, M., Wietelmann, A., … Pullamsetti, S. S. (2015). 5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure. BioMed Research, 2015, 438403, 8 pages. https://doi.org/10.1155/2015/438403
Kankaanranta, H., Harju, T., Kilpeläinen, M., Mazur, W., Lehto, J. T., Katajisto, M., … Lehtimäki, L. (2015). Diagnosis and Pharmacotherapy of Stable Chronic Obstructive Pulmonary Disease: The Finnish Guidelines. Basic & Clinical Pharmacology & Toxicology, 116, 291-307. https://doi.org/10.1111/bcpt.12366
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010). Animal research: Reporting in vivo experiments: the ARRIVE guidelines. British Journal of Pharmacology, 160, 1577-1579.
Kleinerman, J., Ranga, V., Rynbrandt, D., Sorensen, J., & Powers, J. C. (1980). The effect of the specific elastase inhibitor, alanyl prolyl alanine chloromethylketone, on elastase-induced emphysema. The American Review of Respiratory Disease, 121, 381-387. https://doi.org/10.1164/arrd.1980.121.2.381
Kuhn, C. 3rd, & Tavassoli, F. (1976). The scanning electron microscopy of elastase-induced emphysema. A comparison with emphysema in man. Laboratory Investigation, 34, 2-9.
Kurimoto, E., Miyahara, N., Kanehiro, A., Waseda, K., Taniguchi, A., Ikeda, G., … Tanimoto, M. (2013). IL-17A is essential to the development of elastase-induced pulmonary inflammation and emphysema in mice. Respiratory Research, 14, 5. https://doi.org/10.1186/1465-9921-14-5
Lanzetti, M., da Costa, C. A., Nesi, R. T., Barroso, M. V., Martins, V., Victoni, T., … Valença, S. S. (2012). Oxidative stress and nitrosative stress are involved in different stages of proteolytic pulmonary emphysema. Free Radical Biology & Medicine, 53, 1993-2001. https://doi.org/10.1016/j.freeradbiomed.2012.09.015
Lesauskaite, V., & Ebejer, M. J. (1999). Age-Related Changes in the Respiratory System. Maltese Medical Journal, 11, 25-30.
Lüthje, L., Raupach, T., Michels, H., Unsöld, B., Hasenfuss, G., Kögler, H., & Andreas, S. (2009). Exercise intolerance and systemic manifestations of pulmonary emphysema in a mouse model. Respiratory Research, 10, 7-7. https://doi.org/10.1186/1465-9921-10-7
Mattson, J. P., Sun, J., Murray, D. M., & Poole, D. C. (2002). Lipid peroxidation in the skeletal muscle of hamsters with emphysema. Pathophysiology, 8, 215-221. https://doi.org/10.1016/s0928-4680(02)00011-1
Mead, J., Turner, J. M., Macklem, P. T., & Little, J. B. (1967). Significance of the relationship between lung recoil and maximum expiratory flow. Journal of Applied Physiology, 22, 95-108. https://doi.org/10.1152/jappl.1967.22.1.95
Meyer, K. C. (2005). Aging. Proceedings of the American Thoracic Society, 2, 433-439.
Minai, O. A., Chaouat, A., & Adnot, S. (2010). Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest, 137, 39s-51s.
Munoz-Barrutia, A., Ceresa, M., Artaechevarria, X., Montuenga, L. M., & Ortiz-de-Solorzano, C. (2012). Quantification of lung damage in an elastase-induced mouse model of emphysema. International Journal of Biomedical Imaging, 2012, 734734.
Okamoto, T., Akaike, T., Sawa, T., Miyamoto, Y., van der Vliet, A., & Maeda, H. (2001). Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. The Journal of Biological Chemistry, 276, 29596-29602. https://doi.org/10.1074/jbc.M102417200
Oliveira, M. V., Abreu, S. C., Padilha, G. A., Rocha, N. N., Maia, L. A., Takiya, C. M., … Rocco, P. R. (2016). Characterization of a Mouse Model of Emphysema Induced by Multiple Instillations of Low-Dose Elastase. Frontiers in Physiology, 7, 457.
Otto-Verberne, C. J., Ten Have-Opbroek, A. A., Franken, C., Hermans, J., & Dijkman, J. H. (1992). Protective effect of pulmonary surfactant on elastase-induced emphysema in mice. The European Respiratory Journal, 5, 1223-1230.
Padilha, G. A., Henriques, I., Lopes-Pacheco, M., Abreu, S. C., Oliveira, M. V., Morales, M. M., … Rocco, P. R. (2015). Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema. Frontiers in Physiology, 6, 267.
Prakash Muyal, J., Kumar, D., Kotnala, S., Muyal, V., & Kumar Tyagi, A. (2015). Recombinant Human Keratinocyte Growth Factor Induces Akt Mediated Cell Survival Progression in Emphysematous Mice. Archivos de Bronconeumología, 51, 328-337. https://doi.org/10.1016/j.arbres.2014.04.019
Pryor, W. A., & Squadrito, G. L. (1995). The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. The American Journal of Physiology, 268, L699-L722.
Radi, R. (2013). Peroxynitrite, a stealthy biological oxidant. The Journal of Biological Chemistry, 288, 26464-26472.
R Core Team. (2019). R: A language and environment for statistical computing. R foundation for statistical computing, Vienna, Austria. URL https://www.R-project.org/
Rosas-Arellano, A., Villalobos-Gonzalez, J. B., Palma-Tirado, L., Beltran, F. A., Carabez-Trejo, A., Missirlis, F., & Castro, M. A. (2016). A simple solution for antibody signal enhancement in immunofluorescence and triple immunogold assays. Histochemistry and Cell Biology, 146, 421-430. https://doi.org/10.1007/s00418-016-1447-2
Russell, W. M. S., & Burch, R. L. (1959). The Principles of Humane Experimental Technique. Methuen: Methuen Publishing.
Sangani, R. G., & Ghio, A. J. (2011). Lung injury after cigarette smoking is particle related. International Journal of Chronic Obstructive Pulmonary Disease, 6, 191-198. https://doi.org/10.2147/COPD.S14911
Seimetz, M., Parajuli, N., Pichl, A., Veit, F., Kwapiszewska, G., Weisel, F. C., … Weissmann, N. (2011). Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice. Cell, 147, 293-305. https://doi.org/10.1016/j.cell.2011.08.035
Sharma, G., & Goodwin, J. (2006). Effect of aging on respiratory system physiology and immunology. Clinical Interventions in Aging, 1, 253-260. https://doi.org/10.2147/ciia.2006.1.3.253
Snider, G. L., Kleinerman, J., Thurlbeck, W. M., & Bengali, Z. (1985). The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. The American Review of Respiratory Disease, 132, 182-185.
Snider, G. L., Lucey, E. C., & Stone, P. J. (1986). Animal models of emphysema. The American Review of Respiratory Disease, 133, 149-169. https://doi.org/10.1164/arrd.1986.133.1.149
Stenger, S., Thuring, H., Rollinghoff, M., Manning, P., & Bogdan, C. (1995). L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo. European Journal of Pharmacology, 294, 703-712. https://doi.org/10.1016/0014-2999(95)00618-4
Suki, B., Bartolak-Suki, E., & Rocco, P. R. M. (2017). Elastase-Induced Lung Emphysema Models in Mice. Methods in Molecular Biology, 1639, 67-75. https://doi.org/10.1007/978-1-4939-7163-3_7
Supinski, G. S., & Kelsen, S. G. (1982). Effect of elastase-induced emphysema on the force-generating ability of the diaphragm. The Journal of Clinical Investigation, 70, 978-988. https://doi.org/10.1172/jci110709
Szabo, C., Ischiropoulos, H., & Radi, R. (2007). Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nature Reviews. Drug Discovery, 6, 662-680. https://doi.org/10.1038/nrd2222
Takahashi, S., Nakamura, H., Seki, M., Shiraishi, Y., Yamamoto, M., Furuuchi, M., … Ishizaka, A. (2008). Reversal of elastase-induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology, 294, L882-L890. https://doi.org/10.1152/ajplung.00238.2007
Tanaka, K., Ishihara, T., Sugizaki, T., Kobayashi, D., Yamashita, Y., Tahara, K., … Sato, K. (2013). Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease. Nature Communications, 4, 2686. https://doi.org/10.1038/ncomms3686
Valentine, R., Rucker, R. B., Chrisp, C. E., & Fisher, G. L. (1983). Morphological and biochemical features of elastase-induced emphysema in strain A/J mice. Toxicology and Applied Pharmacology, 68, 451-461. https://doi.org/10.1016/0041-008x(83)90290-9
Vidal, D., Fortunato, G., Klein, W., Cortizo, L., Vasconcelos, J., Ribeiro-Dos-Santos, R., … Macambira, S. (2012). Alterations in pulmonary structure by elastase administration in a model of emphysema in mice is associated with functional disturbances. Revista Portuguesa de Pneumologia, 18, 128-136. https://doi.org/10.1016/j.rppneu.2011.12.007
Weissmann, N., Lobo, B., Pichl, A., Parajuli, N., Seimetz, M., Puig-Pey, R., … Barberà, J. A. (2014). Stimulation of soluble guanylate cyclase prevents cigarette smoke-induced pulmonary hypertension and emphysema. American Journal of Respiratory and Critical Care Medicine, 189, 1359-1373. https://doi.org/10.1164/rccm.201311-2037OC
Whiteman, M., & Halliwell, B. (1997). Prevention of peroxynitrite-dependent tyrosine nitration and inactivation of alpha1-antiproteinase by antibiotics. Free Radical Research, 26, 49-56. https://doi.org/10.3109/10715769709097783
Yildirim, A. O., Muyal, V., John, G., Muller, B., Seifart, C., Kasper, M., & Fehrenbach, H. (2010). Palifermin induces alveolar maintenance programs in emphysematous mice. American Journal of Respiratory and Critical Care Medicine, 181, 705-717. https://doi.org/10.1164/rccm.200804-573OC
Yu, A. Y., Frid, M. G., Shimoda, L. A., Wiener, C. M., Stenmark, K., & Semenza, G. L. (1998). Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. The American Journal of Physiology, 275, L818-L826. https://doi.org/10.1152/ajplung.1998.275.4.L818